New drug pipeline monitor.: H79-5E-PDF
"The New Drug Pipeline Monitor (NDPM) provides information on drugs currently under development that may have an impact on future drug plan expenditures in Canada. This publication contains a select list of pipeline drugs that are in Phase III clinical trials or under review by the US Food and Drug Administration (FDA) and that demonstrate the potential to have a significant clinical impact. The BioPharm Insight database is the main data source for this drug selection"--Executive summary, 2014.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.507462&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board. |
|---|---|
| Title | New drug pipeline monitor. |
| Publication type | Series |
| Language | [English] |
| Other language editions | [French] |
| Continued by | Meds pipeline monitor ... ; 2562-3834 ; Began with 2018. |
| Format | Electronic |
| Note(s) | "National Prescription Drug Utilization Information System (NPDUIS)." Issued also in French under title: L'observateur des médicaments émergents. |
| Publishing information | Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2007-2015. |
| Chronology | Began with 2007; ceased with 2015. |
| Frequency | Annual (Irregular) |
| ISSN | 2292-3136 |
| Catalogue number |
|
| Subject terms | Drugs Research and development |
| Issues | 2015 Click to expand
2014 Click to expand
|
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: